CKPT - Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Checkpoint Therapeutics Inc. (CKPT) | Benzinga

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Checkpoint Therapeutics, Inc. ("Checkpoint" or the "Company") (NYSE:CKPT) securities between March 10, 2021 and December 15, 2023, inclusive (the "Class Period"). The Complaint in the lawsuit seeks to recover damages for the Company's investors under the federal securities laws.

The Complaint alleges that Defendants made materially false and misleading statements regarding the Company's business, operations, and compliance policies. Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (i) Checkpoint had overstated its oversight of, and/or its establishment of adequate manufacturing standards ...

CKPT)>Full story available on Benzinga.com